
Day Return
YTD Return
1-Year Return
3-Year Return
5-Year Return
Note: Sector performance is calculated based on the previous closing price of all sector constituents
Industries in This Sector
Select an Industry for a Visual Breakdown
| Industry | Market Weight | YTD Return | |
|---|---|---|---|
| All Industries | 100.00% | 4.86% | |
| Drug Manufacturers - General | 42.35% | 17.56% | |
| Biotechnology | 12.21% | 0.85% | |
| Medical Devices | 11.45% | -0.82% | |
| Diagnostics & Research | 9.54% | -7.43% | |
| Healthcare Plans | 7.56% | -7.88% | |
| Medical Instruments & Supplies | 6.68% | -3.47% | |
| Medical Distribution | 3.29% | 10.37% | |
| Medical Care Facilities | 3.21% | 10.74% | |
| Drug Manufacturers - Specialty & Generic | 2.57% | 1.94% | |
| Health Information Services | 1.14% | -38.47% | |
| Pharmaceutical Retailers | 0.00% | -16.09% | |
Note: Percentage % data on heatmap indicates Day Return
All Industries
--
<= -3
-2
-1
0
1
2
>= 3
Largest Companies in This Sector
View MoreName | Last Price | 1Y Target Est. | Market Weight | Market Cap | Day Change % | YTD Return | Avg. Analyst Rating |
|---|---|---|---|---|---|---|---|
| 1,013.83 | 1,202.37 | 13.18% | 956.403B | -0.66% | -5.66% | Buy | |
| 244.95 | 231.25 | 8.14% | 590.305B | -0.02% | +18.36% | Buy | |
| 225.98 | 246.63 | 5.51% | 399.394B | -1.20% | -1.10% | Buy | |
| 121.10 | 124.89 | 4.17% | 302.482B | -0.46% | +15.05% | Buy | |
| 287.85 | 364.62 | 3.59% | 260.746B | -0.12% | -12.80% | Buy | |
| 376.94 | 350.04 | 2.80% | 203.173B | -0.73% | +15.16% | Buy | |
| 112.66 | 133.39 | 2.70% | 196.08B | -0.56% | -10.08% | Buy | |
| 509.61 | 666.46 | 2.64% | 191.463B | -0.77% | -12.05% | Buy | |
| 151.59 | 155.42 | 2.59% | 188.072B | -0.75% | +23.50% | Buy | |
| 501.60 | 611.82 | 2.46% | 178.133B | +0.17% | -11.43% | Buy |
Investing in the Healthcare Sector
Start Investing in the Healthcare Sector Through These ETFs and Mutual Funds
ETF Opportunities
View MoreName | Last Price | Net Assets | Expense Ratio | YTD Return |
|---|---|---|---|---|
| 156.78 | 40.98B | 0.08% | +1.28% | |
| 289.50 | 19.812B | 0.09% | +0.57% | |
| 173.13 | 8.534B | 0.44% | +2.58% | |
| 124.66 | 8.336B | 0.35% | +2.24% | |
| 100.38 | 4.621B | 0.40% | +3.06% |
Mutual Fund Opportunities
View MoreName | Last Price | Net Assets | Expense Ratio | YTD Return |
|---|---|---|---|---|
| 209.40 | 39.263B | 0.32% | +2.36% | |
| 88.29 | 39.263B | 0.32% | +2.37% | |
| 145.79 | 19.812B | 0.09% | +1.29% | |
| 134.20 | 15.226B | 0.00% | +0.74% | |
| 11.18 | 15.226B | 0.00% | +0.66% |
Healthcare Research
View MoreDiscover the Latest Analyst and Technical Research for This Sector
Analyst Report: Gilead Sciences, Inc.
Gilead Sciences is a biopharmaceutical company that researches, develops, and sells therapies for treating HIV, hepatitis B, hepatitis C, and certain cancers. In October 2020, Gilead's Veklury (remdesivir) became the first approved treatment for COVID-19 in the U.S. Founded in 1987, the company is based in Foster City, California. It has operations in more than 40 countries and more than 18,000 employees.
RatingPrice TargetMarket Digest: GILD, NJR, XYL, TWLO, FOXA
We've used this space to highlight cautious insider sentiment so far in 2026, this based on weekly data from Vickers Stock Research. While the stock market has been volatile, the past 30 days have left the S&P 500 off 0.85%, the Nasdaq down 3.2%, and the DJIA up 0.61%. Turning to the broad insider-sentiment indicators from Vickers, the NYSE Eight-Week Sell/Buy is worse this week than last, at 5.61, and just below the bearish zone that runs from 6.0 and up. The Nasdaq eight-week ratio is a little better this week at 6.09, but remains bearish. And finally, the Total (all exchanges) ratio is flat week over week at a neutral, but almost bearish, 5.77. Things get interesting when we look at Vickers' sector sell/buy ratios. Energy, the top-performing sector year to date according to Bloomberg, now logs a neutral eight-week ratio, having been bullish. Are Energy insiders starting to take profits? Meanwhile, Financial, Bloomberg's worst-performer, sports a bullish ratio (and has for a few weeks now). Are Financial insiders seeing value? And finally, Information Technology, also a bottom-of-the-list performer, had Vickers' only bearish ratio for the past several weeks. But this week, it has improved to neutral. Perhaps these insiders are starting to see a light at the end of the sector tunnel. From a shorter-term sector perspective, only one sector delivered a bullish one-week sell/buy ratio this week: Healthcare. Last week, the sector rang in at neutral. This week, analysts at Vickers highlighted insider transactions of interest at Delta Air Lines Inc. (NYSE: DAL) and Cleveland-Cliffs Inc. (NYSE: CLF).
Daily – Vickers Top Insider Picks for 02/19/2026
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
Daily – Vickers Top Buyers & Sellers for 02/19/2026
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.



















